Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul 3:11:145.
doi: 10.1186/1471-2474-11-145.

Bone metastases from renal cell carcinoma: patient survival after surgical treatment

Andreas Fottner  1 , Melinda Szalantzy, Lilly Wirthmann, Michael Stähler, Andrea Baur-Melnyk, Volkmar Jansson, Hans Roland Dürr
Affiliations

Bone metastases from renal cell carcinoma: patient survival after surgical treatment

Andreas Fottner et al. BMC Musculoskelet Disord. .

Abstract

Background: Surgery is the primary treatment of skeletal metastases from renal cell carcinoma, because radiation and chemotherapy frequently are not effecting the survival. We therefore explored factors potentially affecting the survival of patients after surgical treatment.

Methods: We retrospectively reviewed 101 patients operatively treated for skeletal metastases of renal cell carcinoma between 1980 and 2005. Overall survival was calculated using the Kaplan-Meier method. The effects of different variables were evaluated using a log-rank test.

Results: 27 patients had a solitary bone metastasis, 20 patients multiple bone metastases and 54 patients had concomitant visceral metastases. The overall survival was 58% at 1 year, 37% at 2 years and 12% at 5 years. Patients with solitary bone metastases had a better survival (p < 0.001) compared to patients with multiple metastases. Age younger than 65 years (p = 0.036), absence of pathologic fractures (p < 0.001) and tumor-free resection margins (p = 0.028) predicted higher survival. Gender, location of metastases, time between diagnosis of renal cell carcinoma and treatment of metastatic disease, incidence of local recurrence, radiation and chemotherapy did not influence survival.

Conclusions: The data suggest that patients with a solitary metastasis or a limited number of resectable metastases are candidates for wide resections. As radiation and chemotherapy are ineffective in most patients, surgery is a better option to achieve local tumor control and increase the survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A Kaplan-Meier survival curve of patients based on the metastatic pattern shows that patients with solitary bone metastases had a better survival (p < 0.001) than patients with multiple bone metastases or additional visceral metastases.
Figure 2
Figure 2
A Kaplan-Meier survival curve of patients based on the surgical margin according to the Enneking classification [16]shows that patients with a tumor-free resection margin have a better survival rat (p = 0.028) than patients with a tumor-infiltrated resection margin.
Figure 3
Figure 3
A Kaplan-Meier survival curve of patients stratified on the basis of being diagnosed as "free of disease" or not shows that patients with the diagnosis "free of disease" at any time after the operation had a better survival (p < 0.001).
Figure 4
Figure 4
A Kaplan-Meier survival curve of patients based on whether a pathologic fracture was present before the operation or not shows that presence of a pathologic fracture decreases the prognosis of the patient (p < 0.001).
See this image and copyright information in PMC

References

    1. McLaughlin JK, Lipworth L. Epidemiologic aspects of renal cell cancer. Semin Oncol. 2000;27:115–123. - PubMed
    1. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA. 1999;5;281(17):1628–31. doi: 10.1001/jama.281.17.1628. - DOI - PubMed
    1. Patard JJ, Kim HL, Lam JS, Dorey FJ, Pantuck AJ, Zisman A, Ficarra V, Han KR, Cindolo L, De La Taille A, Tostain J, Artibani W, Dinney CP, Wood CG, Swanson DA, Abbou CC, Lobel B, Mulders PF, Chopin DK, Figlin RA, Belldegrun AS. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol. 2004;15;22(16):3316–22. doi: 10.1200/JCO.2004.09.104. - DOI - PubMed
    1. Han KR, Pantuck AJ, Bui MH, Shvarts O, Freitas DG, Zisman A, Leibovich BC, Dorey FJ, Gitlitz BJ, Figlin RA, Belldegrun AS. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. Urology. 2003;61(2):314–9. doi: 10.1016/S0090-4295(02)02163-5. - DOI - PubMed
    1. Zekri J, Ahmed N, Coleman RE, Hancock BW. The skeletal metastatic compli cations of renal cell carcinoma. Int J Oncol. 2001;19(2):379–82. - PubMed

MeSH terms